SIRS-Lab GmbH Jena | Unique Molecular Diagnostics

SIRS-Lab produces molecular diagnostic test-systems to identify life-threatening infections. The main objective is to enable early and targeted antibiotic therapy of sepsis, a leading cause of death in hospitals. With expert knowledge in critical care medicine, microbiology, assay design, and gene expression, SIRS-Lab builds a unique diagnostic portfolio.

30.06.08
Pre-announcement of new test for sepsis prediction and monitoring
SIRS-Lab introduces a new diagnostic concept for the early prediction and reliable monitoring of sepsis. The molecular diagnostic test “SIQNATURE” delivers the earliest possible information about the potential development of a systemic infection. It further is a unique tool to monitor the progression of sepsis.
read more »

20.06.08
Three Innovation Awards for SIRS-Lab
SIRS-Lab GmbH and the Institute for Medical Microbilogy from the Jena University were jointly awarded with the IQ Innovation Award of central Germany. Additionally, the company and its partners received the cluster award “Biotechnology and Lifescience” and the regional award of Jena. The jury underlined the social and economical relevance of the clinical diagnostic system VYOO, for which SIRS-Lab received the award.
read more »